Latest news

BDD Completes Successful Dosing of all Patients, on Schedule, in Head-to-Head Clinical Study of Investigational Subcutaneous Furosemide (SQIN-Furosemide)

Latest blog posts

Protected: ISLANDS: Integrated Scottish Liver And metabolic Disease Study. Building a National Platform for MASLD Research, Biomarker Discovery and Trial Readiness in Scotland

25 Years of BDD: From Spin-out to Lean Clinical Development™